Optimizing Ligand Efficiency of Selective Androgen Receptor Modulators (SARMs).

ACS Med Chem Lett

Metabolic Pathways Cardiovascular Unit and Platform Technology & Science, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406-0939, United States.

Published: January 2016

A series of selective androgen receptor modulators (SARMs) containing the 1-(trifluoromethyl)benzyl alcohol core have been optimized for androgen receptor (AR) potency and drug-like properties. We have taken advantage of the lipophilic ligand efficiency (LLE) parameter as a guide to interpret the effect of structural changes on AR activity. Over the course of optimization efforts the LLE increased over 3 log units leading to a SARM 43 with nanomolar potency, good aqueous kinetic solubility (>700 μM), and high oral bioavailability in rats (83%).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716610PMC
http://dx.doi.org/10.1021/acsmedchemlett.5b00377DOI Listing

Publication Analysis

Top Keywords

androgen receptor
12
ligand efficiency
8
selective androgen
8
receptor modulators
8
modulators sarms
8
optimizing ligand
4
efficiency selective
4
sarms series
4
series selective
4
sarms 1-trifluoromethylbenzyl
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!